Answers are grounded in this paper and cite their sources.
The prevalence of chronic kidney disease (CKD) has increased by 29.3%, and the all-age mortality rate from CKD has increased by 41.5% since 1990 worldwide.1 The overwhelming fatigue, complex treatment regimens, and diet restrictions constraining the lives of patients with CKD increases their psychological distress,2 which can induce hyperactivity of the hypothalamus-pituitary-adrenal axis, the commonest neurobiological change observed in depressive patients.3 The lifetime prevalence of depression is 10.8% in the general population,4 whereas in CKD stage 5D patients, it is 22.8% based on the interview method and 39.3% based on self- or clinician-administered rating scales, according to a meta-analysis in 2013.
No takes yet. Share an insight, caveat, or question.
Muthukumaran et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: